Adjuvant Systemic Therapy in Breast Cancer: All 3 Major Types (HR+/HER2-, HER2-positive, Triple-Negative)

This workshop explores advancements in breast cancer adjuvant therapy with a focus on molecular subtypes and tailored treatments. Attendees will delve into systemic therapy approaches, innovations like CDK4/6 inhibitors, hormone therapy progress, targeted treatments for HER2-positive cancer, and challenges in triple-negative subtypes. Case studies from trials like NATALEE and monarchE will highlight clinical evidence and safety profiles. Through interactive discussions, participants will...